Creative Financial Designs’s Viking Therapeutics VKTX Stock Holding History

Creative Financial Designs’s Portfolio VKTX Stock Details VKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13K	Hold	400	–	–	﹤0.01%	1333
2025 Q4	$14.1K	Hold	400	–	–	﹤0.01%	1259
2025 Q3	$10.5K	Hold	400	–	–	﹤0.01%	1352
2025 Q2	$10.6K	Sell	400 -2	-0.5%	-$53	﹤0.01%	1328
2025 Q1	$9.71K	Buy	402 +2	+0.5%	+$63	﹤0.01%	1311
2024 Q4	$16.1K	Hold	400	–	–	﹤0.01%	1103
2024 Q3	$25.3K	Hold	400	–	–	﹤0.01%	977
2024 Q2	$21.2K	Hold	400	–	–	﹤0.01%	989
2024 Q1	$32.8K	Hold	400	–	–	﹤0.01%	847
2023 Q4	$7.44K	Hold	400	–	–	﹤0.01%	1173
2023 Q3	$4.43K	Hold	400	–	–	﹤0.01%	1207
2023 Q2	$6.48K	Buy	+400	New	+$8.38K	﹤0.01%	1121
2021 Q4	–	Sell	-533	Closed	-$3K	–	1450
2021 Q3	$3K	Hold	533	–	–	﹤0.01%	1270
2021 Q2	$3K	Hold	533	–	–	﹤0.01%	1284
2021 Q1	$3K	Hold	533	–	–	﹤0.01%	1180
2020 Q4	$3K	Hold	533	–	–	﹤0.01%	1094
2020 Q3	$3K	Hold	533	–	–	﹤0.01%	1057
2020 Q2	$4K	Buy	+533	New	+$3.54K	﹤0.01%	936

Other funds holding VKTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Creative Financial Designs's VKTX Position: Q1 2026 in Review

Creative Financial Designs held its Viking Therapeutics (VKTX) position steady in Q1 2026 at 400 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #1333.

Creative Financial Designs first reported a position in VKTX in Q2 2020 and has held it in 18 quarters since. The position peaked at $32.8K in Q1 2024. 410 funds tracked by Wall St. Rank hold VKTX as of Q1 2026.

Creative Financial Designs held 400 shares of Viking Therapeutics worth $13K as of Q1 2026.
Creative Financial Designs left its Viking Therapeutics share count unchanged in Q1 2026.
Viking Therapeutics made up ﹤0.01% of Creative Financial Designs's portfolio in Q1 2026, its #1333 holding.
Creative Financial Designs first reported a position in Viking Therapeutics in Q2 2020 and has held it in 18 quarters since.
Creative Financial Designs's Viking Therapeutics position peaked at $32.8K in Q1 2024.
410 funds tracked by Wall St. Rank held Viking Therapeutics as of Q1 2026.

Based on Creative Financial Designs's 13F filing for Q1 2026, filed 13 Apr 2026.